Clinical Trial Update: Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study comparing vildagliptin versus a thiazolidinedione as add-on therapy to metformin in adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Thiazolidinedione (unspecified)
• Vildagliptin (Galvus) (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED